Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial

Watchlist | Portfolio

Arena Pharmaceuticals (ARNA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Balance Sheet for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	12-2021	12-2020	12-2019	12-2018	12-2017
Assets
Current Assets
Cash & Cash Equivalents	224,572	219,544	243,274	161,037	158,837
Marketable Securities	325,897	884,497	496,291	284,594	88,240
Receivables	N/A	N/A	N/A	5,086	14,382
Other current assets	0	0	0	0	17,140
TOTAL	$569,465	$1,139,307	$759,934	$460,725	$281,280

Non-Current Assets
PPE Net	19,125	22,090	25,128	23,114	30,131
Investments And Advances	160,796	0	370,938	82,412	24,242
Other Non-Current Assets	35,319	29,323	18,123	120,652	3,622
TOTAL	$215,240	$51,413	$414,189	$226,178	$57,995

Total Assets	$784,705	$1,190,720	$1,174,123	$686,903	$339,275

Liabilities
Current Liabilities
Accounts payable and accrued liabilities	32,135	35,351	25,499	16,181	7,916
Accrued Expenses	29,129	18,325	15,654	10,454	31,706
Other current liabilities	N/A	N/A	N/A	N/A	27,595
TOTAL	$66,316	$58,077	$44,967	$29,918	$72,327

Non-Current Liabilities
Deferred Revenues	N/A	N/A	N/A	N/A	1,110
Other Non-Current Liabilities	8,993	10,963	12,078	1,301	2,314
TOTAL	$45,152	$52,174	$57,691	$50,727	$59,804

Total Liabilities	$111,468	$110,251	$102,658	$80,645	$132,131

Shareholders' Equity
Shares Outstanding, K	61,659	60,335	50,249	49,463	39,402
Common Shares	6	6	5	5	4
Retained earnings	-2,124,164	-1,507,731	-1,102,997	-1,500,552	-1,490,187
Other shareholders' equity	-280	700	1,303	-155	-1,216
TOTAL	$673,237	$1,080,469	$1,071,465	$606,258	$207,144

Total Liabilities And Equity	$784,705	$1,190,720	$1,174,123	$686,903	$339,275